These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 5953740)

  • 1. [Vagomimetic agents in the treatment of functional gastric disorders].
    Bubb WP; Hefti ML
    Praxis; 1966 Oct; 55(40):1144-6. PubMed ID: 5953740
    [No Abstract]   [Full Text] [Related]  

  • 2. [Functional disorders of the digestive tract and possibilities of therapy with Prepulside (cisapride)].
    Hep A; Prásek J; Dítĕ P
    Vnitr Lek; 1995 Mar; 41(3):199-203. PubMed ID: 7762181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacotherapy of gastrointestinal motor disorders.
    Schuurkes JA
    Rev Gastroenterol Mex; 1994; 59(2):165-70. PubMed ID: 7991970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of pyrosis in pregnancy with mestinon].
    WIQVIST N
    Gynaecologia; 1958 Jul; 146(1):65-71. PubMed ID: 13562693
    [No Abstract]   [Full Text] [Related]  

  • 5. [The use of cholinergic drugs in gastroeneterology].
    GUERRE J
    Vie Med; 1956 May; 37(Spec No):85-6. PubMed ID: 13338131
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacological and pharmacokinetic aspects of functional gastrointestinal disorders.
    Camilleri M; Bueno L; de Ponti F; Fioramonti J; Lydiard RB; Tack J
    Gastroenterology; 2006 Apr; 130(5):1421-34. PubMed ID: 16678556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tests of mestinon in surgery and gynecology].
    BIRCHER J
    Schweiz Med Wochenschr; 1953 Dec; 83(49):1190-2. PubMed ID: 13121988
    [No Abstract]   [Full Text] [Related]  

  • 8. Prokinetics and fundic relaxants in upper functional GI disorders.
    Tack J
    Curr Opin Pharmacol; 2008 Dec; 8(6):690-6. PubMed ID: 18940266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological treatment of functional bowel disorders: any light at the end of the tunnel?
    Boeckxstaens GE
    Curr Opin Pharmacol; 2008 Dec; 8(6):669-70. PubMed ID: 18835367
    [No Abstract]   [Full Text] [Related]  

  • 10. Potential pharmacological approaches to management of gut motility disorders.
    Malagelada JR
    Scand J Gastroenterol Suppl; 1984; 96():111-26. PubMed ID: 6382573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review article: drugs interfering with visceral sensitivity for the treatment of functional gastrointestinal disorders--the clinical evidence.
    Kuiken SD; Tytgat GN; Boeckxstaens GE
    Aliment Pharmacol Ther; 2005 Mar; 21(6):633-51. PubMed ID: 15771750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The association of lexotan + propantheline in the treatment of functional gastrointestinal disorders. Controlled clinical study].
    Riva D; Manieri L; Mariano P
    Arch Sci Med (Torino); 1980; 137(3):461-6. PubMed ID: 6112973
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacotherapy for functional gastrointestinal disorders in children.
    Chitkara DK; Di Lorenzo C
    Curr Opin Pharmacol; 2006 Dec; 6(6):536-40. PubMed ID: 16949871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of grandaxin in the treatment of functional gastrointestinal diseases].
    Osipenko MF; Khramov IuA; Makarova TA; Vdovenko EG
    Ter Arkh; 2000; 72(10):23-7. PubMed ID: 11220871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purinergic receptors as future targets for treatment of functional GI disorders.
    Burnstock G
    Gut; 2008 Sep; 57(9):1193-4. PubMed ID: 18719131
    [No Abstract]   [Full Text] [Related]  

  • 16. The effects of drugs on intestinal motility.
    Farrar JT
    Clin Gastroenterol; 1982 Sep; 11(3):673-81. PubMed ID: 7140003
    [No Abstract]   [Full Text] [Related]  

  • 17. Predictors of premature antidepressant discontinuation in functional gastrointestinal disorders.
    Sayuk GS; Elwing JE; Lustman PJ; Clouse RE
    Psychosom Med; 2007; 69(2):173-81. PubMed ID: 17289822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Gastrointestinal motility disorders and drugs: cholinergic, anticholinergic, adrenergic, antiadrenergic and prokinetic drugs (part I)].
    Jovanović-Mićić D; Janković S; Beleslin DB
    Srp Arh Celok Lek; 1994; 122(1-2):50-4. PubMed ID: 17972806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ion channels as targets for treatment of gastrointestinal motility disorders.
    Farrugia G
    Eur Rev Med Pharmacol Sci; 2008 Aug; 12 Suppl 1():135. PubMed ID: 18924455
    [No Abstract]   [Full Text] [Related]  

  • 20. Review article: The rationale for antidepressant therapy in functional gastrointestinal disorders.
    Castle MZ; Silk DB; Libby GW
    Aliment Pharmacol Ther; 2004 May; 19(9):969-79. PubMed ID: 15113363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.